Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy
Year: 2023
Type: article
Abstract: Arrhythmogenic cardiomyopathy is a severe cardiac disorder characterized by lethal arrhythmias and sudden cardiac death, with currently no effective treatment. Plakophilin 2 ( PKP2 ) is the most frequently affected gene. Here we show that adeno-associated virus (AAV)-mediated delivery of PKP2 in PKP2 c.2013delC/WT induced pluripotent stem cell-derived cardiomyocytes restored not only cardiac PKP2 levels but also the levels of other junctional proteins, found to be decreased in response to the mutation. PKP2 restoration improved sodium conduction, indicating rescue of the arrhythmic substrate in PKP2 mutant induced pluripotent stem cell-derived cardiomyocytes. Additionally, it enhanced contractile function and normalized contraction kinetics in PKP2 mutant engineered human myocardium. Recovery of desmosomal integrity and cardiac function was corroborated in vivo, by treating heterozygous Pkp2 c.1755delA knock-in mice. Long-term treatment with AAV9–PKP2 prevented cardiac dysfunction in 12-month-old Pkp2 c.1755delA/WT mice, without affecting wild-type mice. These findings encourage clinical exploration of PKP2 gene therapy for patients with PKP2 haploinsufficiency.
Source: Nature Cardiovascular Research
Institutions: Utrecht University, University Medical Center Utrecht, Nanion (Germany), Universitätsmedizin Göttingen, German Centre for Cardiovascular Research, Multiscale Bioimaging, University of Göttingen, International Centre for Genetic Engineering and Biotechnology, German Center for Neurodegenerative Diseases, Fraunhofer Institute for Translational Medicine and Pharmacology, King's College London, British Heart Foundation
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $11,690
Funders: Deutsches Zentrum für Herz-Kreislaufforschung, Dutch Cardiovascular Alliance, British Heart Foundation, European Commission, Deutsche Forschungsgemeinschaft, Fondation Leducq, Bundesministerium für Bildung und Forschung, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Netherlands Heart Institute
Awards: G1114041275, New-generation cardiac therapeutic strategies directed to the activation of endogenous regenerative mechanisms, G2002282589, G2092439215, G2666578815, G3209406879, Functional selection of novel biotherapeutics for myocardial infarction and heart failure using arrayed AAV libraries coding for the secretome, G4031267587, G584537252, EXC 2067: Multiscale Bioimaging: Von molekularen Maschinen zu Netzwerken erregbarer Zellen, G6094764444, CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease, G7032381815, G772731156, Editing the Failing Heart, G8969797171
OpenAlex ID: W4389439866
